Skip to main content
MEMPHASYS LIMITED. logo

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,225 across all filing types
Latest filing 2010-05-16 Major Shareholding Noti…
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
NSP Change of Interests of substantial holding amended 2 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001 Section 671B, which pertains to notices of change of interests of substantial holders. The content details changes in voting power and relevant interests of a substantial shareholder, including dates and share quantities. This is a formal notification of changes in significant share ownership levels, not a financial report or management announcement. It matches the description of a 'Major Shareholding Notification' which involves notifying changes in significant share ownership thresholds.
2010-05-16 English
Change of Director`s Interest Notice 4 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed disclosures about changes in directors' relevant interests in securities, including dates, number of shares acquired, disposed, and nature of the transactions. It references ASX listing rule 3.19A.2 and the Corporations Act section 205G, which govern insider trading and director shareholding disclosures. The content is focused on personal share transactions by company directors, reporting on their buying activities in the market. There is no financial performance data, earnings information, or management discussion. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades).
2010-05-16 English
NuSep Shareholder Newsletter 4 pages ?Kb
Management Reports Classification · 95% confidence The document is a detailed company newsletter from May 2010, containing operational updates, acquisition details, product launches, sales projections, management appointments, and strategic goals. It includes financial performance highlights such as maiden operational profit, profit projections, and sales targets. The document discusses the acquisition of BioInquire, product innovations, and market strategies. It also announces the appointment of a new VP for Sales. The content is comprehensive and forward-looking, focusing on business performance, strategy, and management updates rather than formal financial statements or regulatory filings. It does not contain full financial statements or detailed quarterly or annual financial data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a simple announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). The document includes management commentary and business outlook, which aligns best with Management Reports (MDA).
2010-05-16 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details a director's change in shareholding, including the number of shares held before and after the change, the nature of the transaction (on-market purchase), and relevant dates. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure of insider trading by a director. There is no financial report, earnings data, or management discussion. The document is a report of personal share transactions by a company director, fitting the definition of Director's Dealing (DIRS). The document length is 2645 characters, which is consistent with a detailed insider transaction notice rather than a full report or announcement of a report.
2010-05-13 English
Change in substantial holding 2 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001 Section 671B, which pertains to notices of change of interests of substantial holders. The content details changes in voting power and relevant interests of a substantial shareholder, including dates and share quantities. This matches the description of a Major Shareholding Notification, which involves reporting changes in significant share ownership levels crossing thresholds. The document is not an annual report, earnings release, or any other financial report type, but a regulatory filing specifically about shareholding changes.
2010-05-12 English
Change of Director`s Interest Notice 4 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed disclosures of changes in directors' relevant interests in securities, including dates, number of shares acquired or disposed, and consideration paid. It references ASX listing rule 3.19A.2 and section 205G of the Corporations Act, which govern director shareholding disclosures. The content is focused on personal share transactions by company directors, not on company financial performance, governance changes, or other report types. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive disclosure of director dealings.
2010-05-10 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.